Rob Ruijtenbeek

1.6k total citations
64 papers, 1.2k citations indexed

About

Rob Ruijtenbeek is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Rob Ruijtenbeek has authored 64 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 20 papers in Radiology, Nuclear Medicine and Imaging and 19 papers in Oncology. Recurrent topics in Rob Ruijtenbeek's work include Monoclonal and Polyclonal Antibodies Research (16 papers), Glycosylation and Glycoproteins Research (11 papers) and Advanced Biosensing Techniques and Applications (8 papers). Rob Ruijtenbeek is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), Glycosylation and Glycoproteins Research (11 papers) and Advanced Biosensing Techniques and Applications (8 papers). Rob Ruijtenbeek collaborates with scholars based in Netherlands, United States and Belgium. Rob Ruijtenbeek's co-authors include Rob M. J. Liskamp, Roland J. Pieters, Riet Hilhorst, Hilbert M. Branderhorst, Marcel J.E. Fischer, Frank A. Redegeld, Nico J. de Mol, Monique Slijper, Albert J. R. Heck and Piet J. Boender and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Rob Ruijtenbeek

63 papers receiving 1.2k citations

Peers

Countries citing papers authored by Rob Ruijtenbeek

Since Specialization

Citations

This map shows the geographic impact of Rob Ruijtenbeek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Ruijtenbeek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Ruijtenbeek more than expected).

Fields of papers citing papers by Rob Ruijtenbeek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Ruijtenbeek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Ruijtenbeek. The network helps show where Rob Ruijtenbeek may publish in the future.

Co-authorship network of co-authors of Rob Ruijtenbeek

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Ruijtenbeek. A scholar is included among the top collaborators of Rob Ruijtenbeek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Ruijtenbeek. Rob Ruijtenbeek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD3-engaging bispecific antibodies trigger a paracrine regulated wave of T-cell recruitment for effective tumor killing 2024 ·Communications Biology ·(unknown), Patrick Engelberts, Andreea Ioan‐Facsinay, (unknown), Thomas Schmidt, Rob Ruijtenbeek, Erik H.J. Danen	5
2	Esterified derivatives of DHA and EPA increase bortezomib cytotoxicity in human multiple myeloma cells 2022 ·European Journal of Pharmacology ·Jing Chen, Rob Ruijtenbeek, Johan Garssen, Frank A. Redegeld	4
3	Time dependent effect of cold ischemia on the phosphoproteome and protein kinase activity in fresh-frozen colorectal cancer tissue obtained from patients 2021 ·Clinical Proteomics ·Tineke E. Buffart, (unknown), (unknown), Riet Hilhorst, (unknown), Hans Pruijt, (unknown), Peet Nooijen, Mariëtte Labots, (unknown), Henk Dekker, Sander R. Piersma, Thang V. Pham, (unknown), Rik de Wijn, Rob Ruijtenbeek, Connie R. Jiménez, Henk M.W. Verheul	3
4	Kinomic profiling of tumour xenografts derived from patients with non–small cell lung cancer confirms their fidelity and reveals potentially actionable pathways 2020 ·European Journal of Cancer ·Fabrizio Tabbò, Francesco Guerrera, (unknown), Marcello Gaudiano, Francesca Maletta, (unknown), Alessia Nottegar, (unknown), Rik de Wijn, Rob Ruijtenbeek, Luisa Delsedime, Anna Sapino, Enrico Ruffini, Riet Hilhorst, Giorgio Inghirami	2
5	Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance 2020 ·Cancers ·Mohammad Krayem, Philippe Aftimos, Ahmad Najem, (unknown), (unknown), (unknown), Rik de Wijn, Riet Hilhorst, Rob Ruijtenbeek, (unknown), Joseph Kerger, Ahmad Awada, Fabrice Journé, Ghanem Ghanem	15
6	Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell line 2019 ·Biochemical Pharmacology ·Nele Van Der Steen, Alessandro Leonetti, Kaylee M. Keller, Henk Dekker, Niccola Funel, Filip Lardon, Rob Ruijtenbeek, Marcello Tiseo, Christian Rolfo, Patrick Pauwels, Godefridus J. Peters, Elisa Giovannetti	13
7	Study of cross talk between phosphatases and OGA on a ZO-3-derived peptide 2019 ·Amino Acids ·(unknown), (unknown), Rob Ruijtenbeek, Roland J. Pieters	5
8	Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids 2018 ·MedChemComm ·Hao Zhang, Tihomir Tomašič, (unknown), (unknown), Rob Ruijtenbeek, Marko Anderluh, Roland J. Pieters	20
9	Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters 2017 ·Molecular Pharmaceutics ·Pedro Caetano-Pinto, (unknown), (unknown), Anastasia G. Goumenou, (unknown), (unknown), Rob Ruijtenbeek, Natalia Sánchez‐Romero, (unknown), Sandra G. Heil, Jitske Jansen, Martijn J. Wilmer, Carla M.L. van Herpen, Rosalinde Masereeuw	30
10	Measuring O-GlcNAc cleavage by OGA and cell lysates on a peptide microarray 2017 ·Analytical Biochemistry ·(unknown), (unknown), (unknown), Rob Ruijtenbeek, Roland J. Pieters	8
11	Activity Based High-Throughput Screening for Novel O-GlcNAc Transferase Substrates Using a Dynamic Peptide Microarray 2016 ·PLoS ONE ·(unknown), (unknown), Rob Ruijtenbeek, Roland J. Pieters	22
12	Cofactor Profiling of the Glucocorticoid Receptor from a Cellular Environment 2014 ·Methods in molecular biology ·Sofie Desmet, Lien Dejager, Dorien Clarisse, (unknown), Diana Melchers, (unknown), Rob Ruijtenbeek, Ilse M. Beck, Claude Libert, René Houtman, Onno C. Meijer, Karolien De Bosscher	16
13	A versatile spectrophotometric protein tyrosine phosphatase assay based on 3-nitrophosphotyrosine containing substrates 2013 ·Analytical Biochemistry ·Jeroen van Ameijde, John Overvoorde, Stefan Knapp, Jeroen den Hertog, Rob Ruijtenbeek, Rob M. J. Liskamp	8
14	Protein Kinase Activity Profiling of Postmortem Human Brain Tissue 2012 ·Neurodegenerative Diseases ·Jeroen J.M. Hoozemans, Riet Hilhorst, Rob Ruijtenbeek, Annemieke J.M. Rozemüller, Saskia M. van der Vies	10
15	Directed Modulation of Protein Kinase C Isozyme Selectivity with Bisubstrate‐Based Inhibitors 2012 ·ChemMedChem ·(unknown), Jeroen van Ameijde, Ahmed S.A. Mady, (unknown), (unknown), Alex J. Poot, Rob Ruijtenbeek, Rob M. J. Liskamp	10
16	Kinome Profiling in Pediatric Brain Tumors as a New Approach for Target Discovery 2009 ·Cancer Research ·Arend H. Sikkema, Sander H. Diks, Wilfred F.A. den Dunnen, Arja ter Elst, Frank J.G. Scherpen, Eelco W. Hoving, Rob Ruijtenbeek, Piet J. Boender, Rik de Wijn, Willem A. Kamps, Maikel P. Peppelenbosch, Eveline S.J.M. de Bont	104
17	Peptide microarrays for detailed, high-throughput substrate identification, kinetic characterization, and inhibition studies on protein kinase A 2009 ·Analytical Biochemistry ·Riet Hilhorst, (unknown), (unknown), Rob Ruijtenbeek	54
18	Protein-Tyrosine Kinase Activity Profiling in Knock Down Zebrafish Embryos 2007 ·PLoS ONE ·Simone Lemeer, Chris Jopling, (unknown), Rob Ruijtenbeek, Monique Slijper, Albert J. R. Heck, Jeroen den Hertog	45
19	Characterization of a phosphorylated peptide and peptoid and peptoid–peptide hybrids by mass spectrometry 2001 ·Journal of Mass Spectrometry ·Rob Ruijtenbeek, Cees Versluis, Albert J. R. Heck, Frank A. Redegeld, Frans P. Nijkamp, Rob M. J. Liskamp	21
20	Kinetic Analysis of the Mass Transport Limited Interaction between the Tyrosine Kinase lck SH2 Domain and a Phosphorylated Peptide Studied by a New Cuvette-Based Surface Plasmon Resonance Instrument 2000 ·Analytical Biochemistry ·Nico J. de Mol, (unknown), Marcel J.E. Fischer, Rob Ruijtenbeek	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact